Global Hemlibra sales increased from CHF 226 Million in 2018 to CHF 1,380 Million in 2019

 
NEW DELHI - May 29, 2020 - PRLog -- Hemlibra is a bispecific factor IXa- and factor X-directed antibody. It is designed to bring together factor IXa and factor X, proteins required to activate the natural coagulation cascade and restore the blood clotting process for people with haemophilia A. Hemlibra is a prophylactic (preventative) treatment that can be administered by an injection of a ready-to-use solution under the skin (subcutaneously) once-weekly, every two weeks or every four weeks (after an initial once weekly dose for the first four weeks). Hemlibra was created by Chugai Pharmaceutical Co., Ltd. and is being co-developed globally by Chugai, Roche and Genentech. It is marketed in the United States by Genentech as Hemlibra (emicizumab-kxwh), with kxwh as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance for Industry issued by the US Food and Drug Administration.

Global Hemlibra sales increased from CHF 226 Million in 2018 to CHF 1,380 Million in 2019.  In the United States, sales grew due to broader market penetration....Please Visits the Link for forecasted revenue: http://www.mngtracker.com/drug/hemlibra

MNG Tracker is a market research company which offer market research reports and database subscription service. No Need to Pay, No Need to SignUp - Just Click and Access the Company Drugs Details. You can access drugs details by company name, by therapeutic area or by drugs name. Each drug details includes drugs revenue globally, regionally and country specific. We also provides the historical and estimated drug revenue along with supportive driving factors.

Drugs Store:  This segment is arranged in three ways. Please click on link to access the information for

By Company Drugs: http://www.mngtracker.com/company-drugs-detail

By Therapeutic Drugs: http://www.mngtracker.com/therapeutic-area-drugs-detail

All Drugs: http://www.mngtracker.com/all-drugs-detail

Thanks and Best Regards
Rohan Dev
Email: rohan.dev@mngtracker.com , info@mngtracker.com
Phone: +91-9013360762
Website: http://mngtracker.com

Contact
Rohan Dev
***@mngtracker.com
End
Source: » Follow
Email:***@mngtracker.com Email Verified
Tags:Company Drugs Revenue
Industry:Research
Location:New Delhi - Delhi - India
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
MNG Tracker PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share